Texas DIR/ESBD #739-SL3800457

Custom Synthesis of Antibody-Drug Conjugates for Texas Tech University Health Sciences Center

Texas Tech University Health Sciences Center (TTUHSC) is seeking qualified firms to provide custom synthesis of antibody-drug conjugates (ADCs) for research purposes. - Government Buyer: - Texas Tech University Health Sciences Center (TTUHSC), part of the Texas Tech University System - Purchasing Office located in Lubbock, Texas - Products/Services Requested: - Custom synthesis of Antibody-Drug Conjugates (ADC) using a proprietary c-MYC inhibitor payload - Scope includes design, synthesis, characterization, and delivery of purified ADCs - Requirements include payload integration, linker selection and optimization, conjugation chemistry, purification, and delivery with Certificate of Analysis and detailed project report (including Drug-to-Antibody Ratio (DAR) analysis and purity profiles) - Notable Requirements: - Firms must possess dual CTCD/CTCM certification - Compliance with Texas state procurement laws and Historically Underutilized Business (HUB) subcontracting requirements - Broad geographic coverage across Texas for potential service delivery - OEMs and Vendors: - No specific OEMs or commercial vendors are named; the procurement is open to qualified firms with relevant expertise - Period of Performance: - Contract anticipated from execution through August 31, 2027, with one optional one-year renewal - Estimated Contract Value: - Approximately $100,000

Description

The Texas Tech University Health Sciences Center (TTUHSC), part of the Texas Tech University System, is seeking proposals from qualified firms to custom synthesize antibody-drug conjugates. The services required are detailed in the solicitation's service specifications section. The project requires firms to have dual CTCD/CTCM certification and covers multiple districts across Texas. The estimated contract value is $100,000.00, and proposals are due by May 26, 2026.

View original listing